Clinical Trial: Indocyangreen Elimination in Cirrhosis and Acute Liver Failure

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure

Brief Summary:

Indocyangreen (ICG)is totally biliary eliminated and corresponds to hepatocyte function and liver perfusion.

The ICG-clearance will be evaluated as a prognostic marker in liver disease.

Detailed Summary: patients with acute liver failure or advanced liver disease will be studied. ICG-clearance will be correlated with established clinical scores and outcome.
Sponsor: Heidelberg University

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Heidelberg University

Dates:
Date Received: October 25, 2005
Date Started: October 2005
Date Completion:
Last Updated: October 8, 2010
Last Verified: November 2008